These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Immunosuppressive mechanisms and action of deoxyspergualin in experimental and clinical studies. Japanese Collaborative Transplant Study Group of NKT-01. Amemiya H Transplant Proc; 1995 Feb; 27(1):31-2. PubMed ID: 7879015 [No Abstract] [Full Text] [Related]
12. Experience gained from the administration of 15-deoxyspergualin for recurrent graft rejection in kidney transplant recipients. Takahara S; Jiang H; Takano Y; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A; Sonoda T Transplant Proc; 1992 Aug; 24(4):1377-80. PubMed ID: 1496592 [No Abstract] [Full Text] [Related]
13. Multicentre clinical trial of antirejection pulse therapy with deoxyspergualin in kidney transplant patients. Amemiya H; Suzuki S; Ota K; Takahashi K; Sonoda T; Ishibashi M; Omoto R; Koyama F; Orita K; Takagi H Int J Clin Pharmacol Res; 1991; 11(4):175-82. PubMed ID: 1813436 [TBL] [Abstract][Full Text] [Related]
14. Outline and long-term prognosis in 15-deoxyspergualin-treated cases. Japan Collaborative Transplant Study Group of NKT-01. Amemiya H; Koyama I; Kyo M; Kozaki K; Yuzawa K; Sakamoto K; Kakefuda T Transplant Proc; 1996 Jun; 28(3):1156-8. PubMed ID: 8658608 [No Abstract] [Full Text] [Related]
15. Effectiveness of 15-deoxyspergualin on renal graft rejection. Kozaki K; Matsuno N; Sakurai E; Tamaki I; Furuhashi K; Saito A; Yoshida M; Miyamoto K; Kozaki M Transplant Proc; 1994 Aug; 26(4):1903-4. PubMed ID: 8066619 [No Abstract] [Full Text] [Related]
16. [The experience of administration of 15-deoxyspergualin on rejection in kidney transplant recipients]. Takano Y; Takahara S; Kokado Y; Kameoka H; Ishibashi M; Jiang H; Okuyama A; Sonoda T Nihon Hinyokika Gakkai Zasshi; 1992 Feb; 83(2):230-5. PubMed ID: 1556843 [TBL] [Abstract][Full Text] [Related]
17. Pilot evaluation of 15-deoxyspergualin for refractory acute renal transplant rejection. Matas AJ; Gores PF; Kelley SL; Bielefield-Skrokov M; Kinaszczuk M; Gruessner RW; Najarian JS Clin Transplant; 1994 Apr; 8(2 Pt 1):116-9. PubMed ID: 8019020 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of 15-deoxyspergualin for rejection in renal transplantation. Kozaki K; Kozaki M; Nagao T Transplant Proc; 1999; 31(1-2):1138-9. PubMed ID: 10083509 [No Abstract] [Full Text] [Related]
19. Local immunosuppression of canine renal allografts with 15-deoxyspergualin. Hughes SE; Xiao S; Perera S; Fluno C; Hasselbarth J; Jayasankar V; Singh J; Del Rosario A; Freed BM; Singh TP; Lempert N; Conti DJ; Gruber SA Transplant Proc; 1996 Aug; 28(4):2054-5. PubMed ID: 8769153 [No Abstract] [Full Text] [Related]
20. 15-Deoxyspergualin "rescue therapy" for methylprednisolone-resistant rejection of renal transplants as compared with anti-T cell monoclonal antibody (OKT3). Okubo M; Tamura K; Kamata K; Tsukamoto Y; Nakayama Y; Osakabe T; Sato K; Go M; Kumano K; Endo T Transplantation; 1993 Mar; 55(3):505-8. PubMed ID: 8456469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]